Brazil Clinical Research Landscape
Panorama da Pesquisa Clínica no Brasil
A portrait of 117 diseases across 14 therapeutic areas: how many patients Brazil's public health system treats, where they are, where they are treated and how many clinical trials already run in Brazil.
5,282
clinical trials with a Brazilian site, 2016–2025
17th
country in the world by clinical trials · 1st in Latin America
117
conditions across 14 therapeutic areas
27
conditions with high SUS burden and few trials
What's inside
- Patients treated in SUS, 2010–2025, new patients, age, sex and race
- Distribution by state and concentration of treating facilities
- Treatment recorded in SUS and hospital admissions
- Clinical trials with a Brazilian site and Brazil's share of trials worldwide
- Why Brazil, the clinical research ecosystem, the opportunity map and the new regulatory framework (Law 14,874/2024 and RDC 945/2024)
Authors
Douglas Andreas Valverde, PharmD
CEO, TechTrials
Elcio Fernandes Firmiano
CIO, TechTrials
Maurício Wesley Perroud, MD
Chief Medical Officer, TechTrials
Valderílio Feijó Azevedo, MD
Rheumatologist; President, Brazilian Society of Rheumatology (SBR)
Paulo Gustavo Kotze, MD
Abel Quaresma, MD
Unoesc — Universidade do Oeste de Santa Catarina
Claudio Ortega, MD
Co-founder, ABRACRO
How to cite: Valverde DA, Firmiano EF, Perroud MW, Azevedo VF, Kotze PG, Quaresma A, Ortega C. Brazil Clinical Research Landscape, 2026 Edition. TechTrials; 2026.
Public, de-identified data from DATASUS and ClinicalTrials.gov. Counts below 10 patients are suppressed, in line with Brazil's data protection law (LGPD). Open access; may be cited freely.
